Somatostatin blockade of acute and chronic stimuli of the endocrine pancreas and the consequences of this blockade on glucose homeostasis.
Open Access
- 1 April 1975
- journal article
- Published by American Society for Clinical Investigation in JCI Insight
- Vol. 55 (4), 754-762
- https://doi.org/10.1172/jci107986
Abstract
The nature and extent of somatostatin-induced inhibition of pancreatic endocrine secretion were studied by administration of a number of stimuli of either glucagon or insulin to over night fasted baboons with and without an infusion of linear somatostatin. The stimuli for acute-phase insulin release were intravenous pulses of glucose, tolbutamide, isoproterenol, and secretin. When given 15 min after the start of a somatostatin infusion, these agents were essentially unable to stimulate insulin secretion. Chronic insulin secretion was stimulated by infusions of either glucose or glucagon. Within 10 min of the start of a super-imposed infusion of somatostatin, insulin levels fell to less than 40 percent of prestimulus control and remained suppressed for the duration of the somatostatin infusion. Stimulation of glucagon secretion by insulin-induced hypoglycemia was also blocked by somatostatin. Plasma glucose decreased during somatostatin infusions except when superimposed upon an infusion of glucagon. Somatostatin had no effect on glucose production in a rat liver slice preparation. We conclude: (a) Somatostatin is a potent and so far universally effective inhibitor of both acute and chronic phases of stimulated insulin and glucagon secretion (b) The inhibitory effect is quickly reversible and the pattern of recovery of secretion is appropriate to prevailing signals; (c) Present evidence suggests that the effect of somatostatin on blood glucose is mediated through its effect on blood glucagon; (d) In the overnight-fasted baboon both in the basal state and 45 min into a 4-mg/kg-min glucose infusion, a somatostatin-induced fall in serum insulin levels appears to be unable to prevent a decrease in hepatic glucose production.Keywords
This publication has 26 references indexed in Scilit:
- Acute effects of insulin on carbohydrate metabolism in rat liver slices: independence from glucagonAmerican Journal of Physiology-Legacy Content, 1974
- EFFECTS OF GROWTH-HORMONE RELEASE-INHIBITING HORMONE ON CIRCULATING GLUCAGON, INSULIN, AND GROWTH HORMONE IN NORMAL, DIABETIC, ACROMEGALIC, AND HYPOPITUITARY PATIENTSThe Lancet, 1974
- INHIBITION OF INSULIN SECRETION BY SOMATOSTATINThe Lancet, 1973
- ACTION OF GROWTH-HORMONE-RELEASE INHIBITORY HORMONE IN HEALTHY MEN AND IN ACROMEGALYThe Lancet, 1973
- Use of Benzamidine as a Proteolytic Inhibitor in the Radioimmunoassay of Glucagon in PlasmaJournal of Clinical Endocrinology & Metabolism, 1972
- Fasting glucose homeostasis in rats after chronic exposure to hypoxiaAmerican Journal of Physiology-Legacy Content, 1970
- Studies of substrate regulation in fastingJCI Insight, 1969
- Determination of Plasma Corticoids by Competitive Protein-Binding Analysis Using Gel FiltrationJournal of Clinical Endocrinology & Metabolism, 1964
- DIAZOXIDE HYPERGLYCÆMIA AND ITS CONTINUED RELIEF BY TOLBUTAMIDEThe Lancet, 1964
- MEASUREMENTS OF ENDOGENOUS GLUCAGON IN PLASMA AND THE INFLUENCE OF BLOOD GLUCOSE CONCENTRATION UPON ITS SECRETION*JCI Insight, 1962